Headwaters Announces Successful Plant Trial

abarrelfullabarrelfull wrote on 13 Oct 2010 10:33
Tags: finland headwaters hydrocracker neste porvoo refınery

Latest News

{"module":"feed\/FeedModule","params":{"src":"http:\/\/killajoules.wikidot.com\/feed\/pages\/pagename\/blog%3A_start\/category\/blog\/limit\/10\/t\/My+Blog","limit":"3","module_body":"* %%linked_title%%"}}
  • Want a weekly review of refining news?

HEADWATERS INCORPORATED (NYSE:HW), in conjunction with Neste Oil Corporation,
announced today the completion of a successful plant trial for its proprietary HCAT™
Hydrocracking Technology at Neste Oil’s Porvoo Refinery. Data from the multi-week
commercial plant trial will be jointly presented by Neste Oil and Headwaters at the “8th
International Bottom-of-the-Barrel Technology Conference” in London on October 6, 2010.

Headwaters’ HCAT technology improves catalytic residue hydrocracking, creating the
possibility of higher residue conversion to lighter transportation fuels such as diesel and gasoline.

HCAT is a proprietary technology where a liquid precursor is introduced with the bottom-of-thebarrel feedstock, generating a highly active molecular catalyst which improves the performance of existing ebullated upgrading units. Process enhancements reported by Neste Oil following the trial include higher residue conversion and less fouling of downstream equipment.

Joni Kunnas, Development Manager of Neste Oil, commented, “We are pleased with the results of our successful plant trial, and we plan to continue testing HCAT in order to evaluate its longer term potential. Our ebullated bed hydrocracking reactor is operating at a higher level of residue conversion and with less fouling in the downstream equipment, due in large part to the hydrogenation activity of the HCAT catalyst.”

Kirk A. Benson, Chairman and CEO of Headwaters, observed, “Operators of ebullated bed
upgraders like Neste Oil’s can anticipate immediate benefits from the combination of their
existing solid catalyst with Headwaters’ liquid catalyst. There are multiple ebullated bed
facilities that could benefit from HCAT. New projects in the early design and developmental stages can also incorporate the HCAT Technology to achieve higher conversion levels than previously thought possible.”

[http://www.headwaters.com/data/upimages/press/10.6.10NestePlantTrial.pdf Headwaters Announces Successful Plant Trial For Heavy Oil Upgradıng Technology At
Neste Oil Porvoo Refınery]

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License